rs2904269

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002827.4(PTPN1):​c.64-21569C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.519 in 151,400 control chromosomes in the GnomAD database, including 21,003 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.52 ( 21003 hom., cov: 29)

Consequence

PTPN1
NM_002827.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.972

Publications

4 publications found
Variant links:
Genes affected
PTPN1 (HGNC:9642): (protein tyrosine phosphatase non-receptor type 1) The protein encoded by this gene is the founding member of the protein tyrosine phosphatase (PTP) family, which was isolated and identified based on its enzymatic activity and amino acid sequence. PTPs catalyze the hydrolysis of the phosphate monoesters specifically on tyrosine residues. Members of the PTP family share a highly conserved catalytic motif, which is essential for the catalytic activity. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP has been shown to act as a negative regulator of insulin signaling by dephosphorylating the phosphotryosine residues of insulin receptor kinase. This PTP was also reported to dephosphorylate epidermal growth factor receptor kinase, as well as JAK2 and TYK2 kinases, which implicated the role of this PTP in cell growth control, and cell response to interferon stimulation. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2013]
PTPN1 Gene-Disease associations (from GenCC):
  • autoinflammatory syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.657 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002827.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTPN1
NM_002827.4
MANE Select
c.64-21569C>A
intron
N/ANP_002818.1A8K3M3
PTPN1
NM_001278618.2
c.-65-25175C>A
intron
N/ANP_001265547.1B4DSN5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTPN1
ENST00000371621.5
TSL:1 MANE Select
c.64-21569C>A
intron
N/AENSP00000360683.3P18031
PTPN1
ENST00000859846.1
c.64-21569C>A
intron
N/AENSP00000529905.1
PTPN1
ENST00000859845.1
c.64-21569C>A
intron
N/AENSP00000529904.1

Frequencies

GnomAD3 genomes
AF:
0.519
AC:
78506
AN:
151282
Hom.:
20964
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.663
Gnomad AMI
AF:
0.424
Gnomad AMR
AF:
0.492
Gnomad ASJ
AF:
0.465
Gnomad EAS
AF:
0.318
Gnomad SAS
AF:
0.377
Gnomad FIN
AF:
0.463
Gnomad MID
AF:
0.365
Gnomad NFE
AF:
0.477
Gnomad OTH
AF:
0.487
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.519
AC:
78604
AN:
151400
Hom.:
21003
Cov.:
29
AF XY:
0.517
AC XY:
38208
AN XY:
73940
show subpopulations
African (AFR)
AF:
0.664
AC:
27415
AN:
41308
American (AMR)
AF:
0.492
AC:
7500
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
0.465
AC:
1607
AN:
3454
East Asian (EAS)
AF:
0.318
AC:
1640
AN:
5156
South Asian (SAS)
AF:
0.377
AC:
1805
AN:
4790
European-Finnish (FIN)
AF:
0.463
AC:
4786
AN:
10338
Middle Eastern (MID)
AF:
0.355
AC:
103
AN:
290
European-Non Finnish (NFE)
AF:
0.477
AC:
32345
AN:
67824
Other (OTH)
AF:
0.484
AC:
1019
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1825
3650
5474
7299
9124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
676
1352
2028
2704
3380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.520
Hom.:
2727
Bravo
AF:
0.528
Asia WGS
AF:
0.374
AC:
1300
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.13
DANN
Benign
0.63
PhyloP100
-0.97
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2904269; hg19: chr20-49156331; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.